These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38995015)

  • 1. Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology.
    Angelopoulou E; Bougea A; Hatzimanolis A; Scarmeas N; Papageorgiou SG
    Cells; 2024 Jul; 13(13):. PubMed ID: 38995015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Naude J; Wang M; Leon R; Smith E; Ismail Z
    Neurobiol Aging; 2024 Jun; 138():19-27. PubMed ID: 38490074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology.
    Sun Y; Xu W; Chen KL; Shen XN; Tan L; Yu JT;
    Transl Psychiatry; 2021 Nov; 11(1):577. PubMed ID: 34759274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC
    Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
    Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease.
    Cassidy CM; Therriault J; Pascoal TA; Cheung V; Savard M; Tuominen L; Chamoun M; McCall A; Celebi S; Lussier F; Massarweh G; Soucy JP; Weinshenker D; Tardif C; Ismail Z; Gauthier S; Rosa-Neto P
    Neuropsychopharmacology; 2022 Apr; 47(5):1128-1136. PubMed ID: 35177805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease.
    Angelopoulou E; Koros C; Hatzimanolis A; Stefanis L; Scarmeas N; Papageorgiou SG
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease.
    Johansson M; Stomrud E; Insel PS; Leuzy A; Johansson PM; Smith R; Ismail Z; Janelidze S; Palmqvist S; van Westen D; Mattsson-Carlgren N; Hansson O
    Transl Psychiatry; 2021 Jan; 11(1):76. PubMed ID: 33500386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
    Xing F; Meng T; Therriault J; Luo J; Zhang H;
    J Integr Neurosci; 2021 Jun; 20(2):277-286. PubMed ID: 34258926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.
    Chandra A; Valkimadi PE; Pagano G; Cousins O; Dervenoulas G; Politis M;
    Hum Brain Mapp; 2019 Dec; 40(18):5424-5442. PubMed ID: 31520513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.
    Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R;
    Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology.
    Mijalkov M; Veréb D; Canal-Garcia A; Hinault T; Volpe G; Pereira JB;
    Alzheimers Res Ther; 2023 Jun; 15(1):112. PubMed ID: 37328909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau.
    McCollum LE; Das SR; Xie L; de Flores R; Wang J; Xie SX; Wisse LEM; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2021; 31():102717. PubMed ID: 34119903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.